New drug trial aims to soothe painful skin rash for cancer patients
NCT ID NCT04697069
Summary
This study tested a drug called imsidolimab to see if it could reduce a painful, acne-like skin rash that is a common side effect of certain cancer treatments. It involved a small group of cancer patients who developed this rash while taking specific targeted therapies. The goal was to see if the drug could safely reduce the number of skin bumps, ease itching and pain, and improve patients' quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACNEIFORM ERUPTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site 101
St Louis, Missouri, 63110, United States
-
Site 102
Tampa, Florida, 33620, United States
-
Site 103
Houston, Texas, 77030, United States
-
Site 105
Columbus, Ohio, 43215, United States
-
Site 106
Boston, Massachusetts, 02215, United States
-
Site 201
Szczecin, 70-784, Poland
-
Site 203
Poznan, 60-569, Poland
-
Site 204
Gliwice, 44-102, Poland
-
Site 301
Olomouc, 779 00, Czechia
-
Site 302
New Town, Praha 2, 128 00, Czechia
-
Site 303
Brno, 656-91, Czechia
-
Site 304
Plzen-Bory, 305 99, Czechia
-
Site 401
Tbilisi, 0186, Georgia
-
Site 402
Tbilisi, 0144, Georgia
-
Site 403
Tbilisi, 0160, Georgia
-
Site 404
Batumi, 6000, Georgia
-
Site 405
Tbilisi, 0160, Georgia
-
Site 601
Riga, 1038, Latvia
Conditions
Explore the condition pages connected to this study.